Literature DB >> 11822773

Antibiotic persistence: the role of spontaneous DNA repair response.

E A Debbia1, S Roveta, A M Schito, L Gualco, A Marchese.   

Abstract

Persisters are a small proportion of a bacterial population that exists in a physiological state permitting survival despite the lethal activity of antibiotics. To explain this phenomenon, it has been suggested that persisters are bacteria repairing spontaneous errors of DNA synthesis. To verify this assumption, Escherichia coli AB1157 and its lexA3 derivative were exposed to a dose 6x MIC of various antibiotics representative of different molecular mechanisms of action (ampicillin, ceftriaxone, meropenem, amikacin, ciprofloxacin). Bacterial cell counts, after 24 hr of exposure to the antimicrobials, revealed a reduction of about 90% of viable organisms in the lexA3 strains in comparison to the lexA+. In several cases, the number of colony-forming units decreased below the limit of assay. This behavior was noted with all antibiotics used, alone or in combination (amikacin plus ceftriaxone and amikacin plus ciprofloxacin). The same experiments were repeated using E. coli AB1157 cultured in the presence of mitomycin C (0.25x MIC), and the number of survivors exceeded by about 90% the values found in the nonexposed control. In contrast, in the sulA background, mitomycin C reacted synergically with all the antibiotics tested causing a strong reduction of the survivors in comparison with the control. The addition of chloramphenicol (0.125x MIC), on the contrary, caused a reduction of the number of survivors of about 90%. These findings indicate that, when DNA repair is active (a mechanism known to block cell division), the number of survivors is greater than that observed with lexA3. Thus, in addition to other possible explanations, persisters might be a fraction of bacteria that during antibiotic treatment are not growing because they are repairing spontaneous errors of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11822773     DOI: 10.1089/10766290152773347

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  16 in total

Review 1.  Heterogeneous bacterial persisters and engineering approaches to eliminate them.

Authors:  Kyle R Allison; Mark P Brynildsen; James J Collins
Journal:  Curr Opin Microbiol       Date:  2011-09-19       Impact factor: 7.934

2.  Trans-translation mediates tolerance to multiple antibiotics and stresses in Escherichia coli.

Authors:  Jinghua Li; Lei Ji; Wanliang Shi; Jianping Xie; Ying Zhang
Journal:  J Antimicrob Chemother       Date:  2013-06-27       Impact factor: 5.790

3.  Power-law tail in lag time distribution underlies bacterial persistence.

Authors:  Emrah Şimşek; Minsu Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

Review 4.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Transcriptional Repressor PtvR Regulates Phenotypic Tolerance to Vancomycin in Streptococcus pneumoniae.

Authors:  Xue Liu; Jing-Wen Li; Zhixing Feng; Youfu Luo; Jan-Willem Veening; Jing-Ren Zhang
Journal:  J Bacteriol       Date:  2017-06-27       Impact factor: 3.490

6.  Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.

Authors:  Marzia Dolcino; Alberto Zoratti; Eugenio A Debbia; Gian Carlo Schito; Anna Marchese
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 7.  Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Authors:  Ben Gold; Carl Nathan
Journal:  Microbiol Spectr       Date:  2017-01

8.  Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development.

Authors:  Danny K C Fung; Edward W C Chan; Miu L Chin; Raphael C Y Chan
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

Review 9.  DNA Replication in Mycobacterium tuberculosis.

Authors:  Zanele Ditse; Meindert H Lamers; Digby F Warner
Journal:  Microbiol Spectr       Date:  2017-03

10.  Why is long-term therapy required to cure tuberculosis?

Authors:  Lynn E Connolly; Paul H Edelstein; Lalita Ramakrishnan
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.